Product Images Pravastatin Sodium

Pravastatin Sodium Tablets, USP 20mg is a medication used to lower high cholesterol and triglycerides in certain patients. It is marketed as a generic alternative to Pravachol. Each tablet contains Pravastatin sodium, USP and the recommended dosage is one tablet to be taken every day. It is important to store the medication at a controlled room temperature of 20°C to 25°C, to protect from light and moisture and to keep it away from children's reach. The medication should not be transferred to anyone other than the patient for whom it was prescribed. The package size, expiration date, lot and batch numbers, and manufacturer's information are available on the package. The medication comes in yellow, rectangle-shaped tablets, imprinted with the code, "20 G." Bilingual instructions are provided in English and Spanish.*

This is a description of Pravastatin Sodium Tablets, USP 10mg manufactured by Glenmark Pharmaceuticals Inc., USA which is the generic version of Pravachol. The tablet is round, yellow and imprinted with G3 10. It contains 10mg pravastatin sodium and each package has an expiry date, lot number, batch number, and production number. The medication should be stored at 20°-25°C°C (77°F) and protected from moisture and light. The direction is to take the tablet(s) prescribed by a doctor, and it's available in different quantities. The barcode on the package has an NDC or prod# and Insurance NDC. It's important to keep this medication out of the reach of children and not transfer it to another person.*

This text appears to be a graphical representation of survival distributions for coronary heart disease death or nonfatal myocardial infarction by proportion of subjects without the event. The graph shows a comparison between placebo and pravastatin using the log-rank statistical test, with a p-value of 0.0001. The x-axis represents years since randomization and the y-axis indicates the proportion of subjects without the event. The graph shows a gradual decrease in the proportion of subjects without the event over time, with the pravastatin line consistently lower than the placebo line.*

This appears to be a chemical formula consisting of CHa, ONa, and C,,HNao with a combined molecular weight of 446.52. It is not clear what the specific compound is or what it is used for.*